Find link

language:

Find link is a tool written by Edward Betts.

searching for Rituximab 62 found (294 total)

alternate case: rituximab

MALT lymphoma (2,138 words) [view diff] exact match in snippet view article find links to article

disseminated disease at presentation or lack of response to local treatment. Rituximab, the anti-CD20 chimeric antibody, is a key component of therapy. Responses

Bullous pemphigoid (1,333 words) [view diff] exact match in snippet view article find links to article

use corticosteroids.[citation needed] The anti-CD20 monoclonal antibody rituximab has been found to be effective in treating some otherwise refractory cases

AJ Kanwar (764 words) [view diff] exact match in snippet view article find links to article

work in Vitiligo. He was also the first in India to report efficacy of Rituximab for treatment of Pemphigus He was selected as a fellow of National Academy

Pemphigoid (5,868 words) [view diff] exact match in snippet view article find links to article

be difficult to treat even with usually effective medications such as rituximab. Bullous pemphigoid (BP) is a rare and chronic autoimmune disorder characterised

Castleman disease (2,400 words) [view diff] exact match in snippet view article find links to article

recommended for symptomatic patients. If symptoms are due to compression, then rituximab is recommended. If symptoms are due to an inflammatory syndrome, then

Primary mediastinal B-cell lymphoma (427 words) [view diff] exact match in snippet view article find links to article

begins with months of multi-drug chemotherapy regimen. Either R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone) or DA-EPOCH-R

Urelumab (1,121 words) [view diff] exact match in snippet view article find links to article

(NCT00351325), chemoradiation (NCT00461110), ipilimumab (NCT00803374), rituximab (NCT01775631, NCT02420938), cetuximab (NCT02110082), and elotuzumab (NCT02252263)

Immunoglobulin A (2,589 words) [view diff] exact match in snippet view article find links to article

be difficult to treat even with usually effective medications such as rituximab. Vancomycin can induce a linear IgA bullous dermatosis in some patients

Nodular sclerosis (188 words) [view diff] exact match in snippet view article find links to article

plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy". Eur. J. Haematol. 79 (5): 455–61. doi:10.1111/j.1600-0609

Rapidly progressive glomerulonephritis (1,029 words) [view diff] exact match in snippet view article find links to article

granulomatosis with polyangiitis. Therapy consists of a combination of rituximab, corticosteroids, and cyclophosphamide, with a substitution of azathioprine

Pidilizumab (301 words) [view diff] exact match in snippet view article find links to article

"Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label

Epratuzumab (377 words) [view diff] exact match in snippet view article find links to article

Nikcevich DA, Kurtin PJ, Cannon MW, et al. (October 2011). "Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy

Pixantrone (2,022 words) [view diff] exact match in snippet view article find links to article

regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab to the same regimen, but substituting Doxorubicin with Pixantrone. The

Pentostatin (604 words) [view diff] exact match in snippet view article find links to article

"Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in

Tower Cancer Research Foundation (1,133 words) [view diff] exact match in snippet view article find links to article

Trial of Immunotherapy With Mitumprotimut-T (Id-KLH) and GM-CSF Following Rituximab in Follicular B-cell Lymphoma - Journal of Immunotherapy Feb/Mar 2010

Fostamatinib (2,274 words) [view diff] exact match in snippet view article find links to article

including corticosteroids, IV immunoglobulin, anti-D, splenectomy, and rituximab. However, there are a significant minority of patients who retain persistently

Granulomatous–lymphocytic interstitial lung disease (904 words) [view diff] exact match in snippet view article find links to article

and cyclophosphamide (1 patient). Partial responses were also seen with rituximab and hydroxychloroquine. In contrast, a second report suggested poor response

Marburg acute multiple sclerosis (808 words) [view diff] exact match in snippet view article find links to article

Meyer Zu Hörste, G.; Hartung, H.-P.; Stüve, O.; Kieseier, B. C. (2008). "Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis

Adele Fielding (906 words) [view diff] exact match in snippet view article find links to article

Taussig D, Yallop D, Alapi KZ, Fielding AK. Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell

Blisibimod (931 words) [view diff] exact match in snippet view article find links to article

Moretti M, Barone F, Bombardieri M, Rupolo M, et al. (2008). "Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial

Iranian National Formulary (98 words) [view diff] case mismatch in snippet view article find links to article

SALMETEROL 127,780,028,000 17 SODIUM CHLORIDE 126,043,613,100 18 IBUPROFEN 125,621,562,500 19 RITUXIMAB 118,690,006,000 20 ERYTHROPOIETIN 110,191,720,000

Mixed autoimmune hemolytic anemia (548 words) [view diff] exact match in snippet view article find links to article

and cold autoantibodies that responded completely to a single cycle of rituximab: a case report". Journal of Medical Case Reports. 5 (1). Springer Nature:

Avadomide (428 words) [view diff] exact match in snippet view article find links to article

(May 2022). "Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and

CD99 (2,292 words) [view diff] exact match in snippet view article find links to article

expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy". Ann. Hematol. 91 (12): 1897–906. doi:10.1007/s00277-012-1533-z

Non-Hodgkin lymphoma (3,190 words) [view diff] exact match in snippet view article find links to article

drugs (cyclophosphamide, doxorubicin, vincristine, and prednisone) plus rituximab. R-CHP with polatuzumab vedotin, an antibody-drug conjugate, was included

Pulmonary alveolar proteinosis (2,251 words) [view diff] exact match in snippet view article find links to article

treatments still being studied include subcutaneous and inhaled GM-CSF, and rituximab, an intravenous infusion that works to stop the production of the autoantibodies

Delayed hemolytic transfusion reaction (1,350 words) [view diff] exact match in snippet view article find links to article

2023-04-29 Noizat-Pirenne F, Bachir D, Chadebech P, et al. (December 2007). "Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell

Hemolytic anemia (3,557 words) [view diff] exact match in snippet view article find links to article

necessary. In steroid resistant cases, consideration can be given to rituximab or addition of an immunosuppressant (azathioprine, cyclophosphamide).

CD20-like family (314 words) [view diff] exact match in snippet view article find links to article

CD20-like family crystal structure of rituximab fab in complex with an epitope peptide Identifiers Symbol CD20 Pfam PF04103 Pfam clan CL0347 InterPro

Complement-dependent cytotoxicity (957 words) [view diff] exact match in snippet view article find links to article

PMID 20176268. The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy. Zhou 2008 Complement dependent

Interferon alpha-1 (2,894 words) [view diff] exact match in snippet view article find links to article

"Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients". Arthritis and Rheumatism. 62 (12):

CD137 (2,323 words) [view diff] exact match in snippet view article find links to article

2016). Phase 1 Study of Utomilumab (PF-05082566) In Combination with Rituximab in Patients with CD20+ NHL (PDF). New Therapies in Hematology. Bologna

Eosinophilic granulomatosis with polyangiitis (2,813 words) [view diff] exact match in snippet view article find links to article

omalizumab, immunomodulation with Interferon-α, and B cell therapy with rituximab—may lead to increasingly personalized treatment regimens for future EGPA

Brunangelo Falini (2,061 words) [view diff] exact match in snippet view article find links to article

More recently, Falini and colleagues reported that vemurafenib plus rituximab induces a durable complete response (often MRD negative) in most patients

Catastrophic antiphospholipid syndrome (1,350 words) [view diff] exact match in snippet view article find links to article

Recent investigational treatment therapies include high doses of Rituxan (Rituximab) and eculizumab, which are both humanized monoclonal antibodies that target

Protein A (1,860 words) [view diff] exact match in snippet view article find links to article

of a VH3 human Fab (left). Minimized protein A bound to Fc fragment of Rituximab (right). Uniprot P02976. Identifiers Symbol SpA Pfam PF02216 InterPro

Fine chemical (12,113 words) [view diff] exact match in snippet view article find links to article

erythropoietin), Enbrel (etanercerpt), Remicade (infliximab); MabThera/Rituxin (rituximab), and Herceptin (trastuzumab). PEGylation is a big step forward regarding

TME Pharma (486 words) [view diff] exact match in snippet view article find links to article

number NCT01486797 for "NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia" at ClinicalTrials.gov "Noxxon

CD47 (4,214 words) [view diff] exact match in snippet view article find links to article

Gill S, et al. (September 2010). "Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma". Cell. 142

Gulácsi László (1,896 words) [view diff] exact match in snippet view article find links to article

antirheumatic drugs (DMARDs) therapies (infliximab, etanercept, tocilizumab, rituximab, abatacept) have become publicly funded in Hungary and patients with rheumatoid

Primary biliary cholangitis (5,849 words) [view diff] exact match in snippet view article find links to article

patients to cope with its impact is effective. Drugs such as coenzyme Q and rituximab have been shown to be ineffective. A graded programme of exercise helps

Schedule H (253 words) [view diff] case mismatch in snippet view article find links to article

RILUZONE 434. RISPERIDONE 435. RITONAVIR 436. RITODRINE HYDROCHLORIDE 437. RITUXIMAB 438. RIVASTIGMINE 439. ROCURONIUM BROMIDE 440. ROPINIROLE 441. ROSOXACIN

Navitoclax (1,295 words) [view diff] exact match in snippet view article find links to article

docetaxel, gemcitabine, and irinotecan), olaparib, erlotinib, venetoclax, and rituximab in advanced hematological malignancies (in both pediatric and adult patients)

Antibody (13,400 words) [view diff] exact match in snippet view article find links to article

doi:10.1056/NEJMoa062382. PMID 17287478. Plosker GL, Figgitt DP (2003). "Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic

Mooren's ulcer (1,606 words) [view diff] exact match in snippet view article find links to article

(2016-07-22). "Management of severe and refractory Mooren's ulcers with rituximab". British Journal of Ophthalmology. 101 (4): 418–422. doi:10

John W. Semple (417 words) [view diff] exact match in snippet view article find links to article

idiopathic thrombocytopenic purpura receiving B-cell depleting therapy with rituximab". Blood. 112 (4): 1147–1150. doi:10.1182/blood-2007-12-129262. PMID 18375792

Lesional demyelinations of the central nervous system (4,846 words) [view diff] exact match in snippet view article find links to article

Waubant E, Arnold DL, et al. (February 2008). "B-cell depletion with rituximab in relapsing-remitting multiple sclerosis". N Engl J Med. 358 (7): 676–88

Pevonedistat (1,034 words) [view diff] exact match in snippet view article find links to article

NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo". Blood. 127 (9): 1128–1137. doi:10.1182/blood-2015-04-640920

Radioligand (4,347 words) [view diff] exact match in snippet view article find links to article

Example of monoclonal antibody (Rituximab) binding to CD20 on B-Cell Surface

Oliver Press (692 words) [view diff] exact match in snippet view article find links to article

CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab". Cancer Immunology Research. 4 (6): 509–519. doi:10.1158/2326-6066.CIR-15-0276

Andrew Pecora (1,642 words) [view diff] exact match in snippet view article find links to article

chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab". Blood. 99 (4): 1486–1488. doi:10.1182/blood.V99.4.1486. PMID 11830505

Anti-VGKC-complex encephalitis (1,570 words) [view diff] exact match in snippet view article find links to article

IVIG, plasmapheresis, glucocorticoids/other immunosuppressant drugs and rituximab.[citation needed] The prognosis with treatment is generally good and much

Sree Bhushan Raju (1,326 words) [view diff] exact match in snippet view article find links to article

Singh R, Pandey RM, Nephrol Dial Transplant. 2005 Aug; 20 (8): 1638–42. Rituximab in the treatment of refractory late acute antibody-mediated rejection:

Jindřich Kopeček (2,548 words) [view diff] exact match in snippet view article find links to article

generation of DMFT. Anti-CD20 antibodies are divided into Type I such as rituximab (RTX) and Type II such as obinutuzumab (OBN); they have different patterns

Cancer associated retinopathy (637 words) [view diff] exact match in snippet view article find links to article

Daniel (2013-11-01). "Treatment of Cancer-Associated Retinopathy With Rituximab". Journal of the National Comprehensive Cancer Network. 11 (11): 1320–1324

Inflammatory demyelinating diseases of the central nervous system (11,718 words) [view diff] exact match in snippet view article find links to article

the use of immunosuppressive therapy (mitoxantrone/cyclophosphamide), rituximab, autologous haematopoietic stem cell therapy or combination therapy should

Reduction-sensitive nanoparticles (3,054 words) [view diff] exact match in snippet view article find links to article

(2017-06-04). "Novel reduction-sensitive micellar nanoparticles assembled from Rituximab-doxorubicin conjugates as smart and intuitive drug delivery systems for

Justine R. Smith (1,233 words) [view diff] exact match in snippet view article find links to article

1136/bjophthalmol-2012-302292 Br J Ophthalmol 2014 Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. doi:10.1136/bjophthalmol-2013-304043

Pathology of multiple sclerosis (17,202 words) [view diff] exact match in snippet view article find links to article

Waubant E, Arnold DL, et al. (February 2008). "B-cell depletion with rituximab in relapsing-remitting multiple sclerosis". New England Journal of Medicine

List of autoimmune diseases (6,053 words) [view diff] exact match in snippet view article find links to article

Rojas-Villarraga, Adriana; Rueda, Juan C.; Anaya, Juan-Manuel (2007-09-22). "Should Rituximab be Considered as the First-Choice Treatment for Severe Autoimmune Rheumatic

Thymidine kinase in clinical chemistry (9,990 words) [view diff] exact match in snippet view article find links to article

patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone". Leukemia

Paul Emery (rheumatologist) (1,477 words) [view diff] exact match in snippet view article

Randall M. Stevens, and Tim Shaw. "Efficacy of B-cell–targeted therapy with rituximab in patients with rheumatoid arthritis." New England Journal of Medicine